Cargando…
Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
Medial temporal lobe atrophy (MTA) is a recognized marker of Alzheimer's disease (AD), however, it can be prominent in frontotemporal lobar degeneration (FTLD). There is an increasing awareness that posterior atrophy (PA) is important in AD and may aid the differentiation of AD from FTLD. Visua...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657170/ https://www.ncbi.nlm.nih.gov/pubmed/21596458 http://dx.doi.org/10.1016/j.neurobiolaging.2011.04.003 |
_version_ | 1782270104771231744 |
---|---|
author | Lehmann, Manja Koedam, Esther L.G.E. Barnes, Josephine Bartlett, Jonathan W. Ryan, Natalie S. Pijnenburg, Yolande A.L. Barkhof, Frederik Wattjes, Mike P. Scheltens, Philip Fox, Nick C. |
author_facet | Lehmann, Manja Koedam, Esther L.G.E. Barnes, Josephine Bartlett, Jonathan W. Ryan, Natalie S. Pijnenburg, Yolande A.L. Barkhof, Frederik Wattjes, Mike P. Scheltens, Philip Fox, Nick C. |
author_sort | Lehmann, Manja |
collection | PubMed |
description | Medial temporal lobe atrophy (MTA) is a recognized marker of Alzheimer's disease (AD), however, it can be prominent in frontotemporal lobar degeneration (FTLD). There is an increasing awareness that posterior atrophy (PA) is important in AD and may aid the differentiation of AD from FTLD. Visual rating scales are a convenient way of assessing atrophy in a clinical setting. In this study, 2 visual rating scales measuring MTA and PA were used to compare atrophy patterns in 62 pathologically-confirmed AD and 40 FTLD patients. Anatomical correspondence of MTA and PA was assessed using manually-delineated regions of the hippocampus and posterior cingulate gyrus, respectively. Both MTA and PA scales showed good inter- and intrarater reliabilities (kappa > 0.8). MTA scores showed a good correspondence with manual hippocampal volumes. Thirty percent of the AD patients showed PA in the absence of MTA. Adding the PA to the MTA scale improved discrimination of AD from FTLD, and early-onset AD from normal aging. These results underline the importance of considering PA in AD diagnosis, particularly in younger patients where medial temporal atrophy may be less conspicuous. |
format | Online Article Text |
id | pubmed-3657170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-36571702013-05-18 Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease Lehmann, Manja Koedam, Esther L.G.E. Barnes, Josephine Bartlett, Jonathan W. Ryan, Natalie S. Pijnenburg, Yolande A.L. Barkhof, Frederik Wattjes, Mike P. Scheltens, Philip Fox, Nick C. Neurobiol Aging Abstract of Online Article Medial temporal lobe atrophy (MTA) is a recognized marker of Alzheimer's disease (AD), however, it can be prominent in frontotemporal lobar degeneration (FTLD). There is an increasing awareness that posterior atrophy (PA) is important in AD and may aid the differentiation of AD from FTLD. Visual rating scales are a convenient way of assessing atrophy in a clinical setting. In this study, 2 visual rating scales measuring MTA and PA were used to compare atrophy patterns in 62 pathologically-confirmed AD and 40 FTLD patients. Anatomical correspondence of MTA and PA was assessed using manually-delineated regions of the hippocampus and posterior cingulate gyrus, respectively. Both MTA and PA scales showed good inter- and intrarater reliabilities (kappa > 0.8). MTA scores showed a good correspondence with manual hippocampal volumes. Thirty percent of the AD patients showed PA in the absence of MTA. Adding the PA to the MTA scale improved discrimination of AD from FTLD, and early-onset AD from normal aging. These results underline the importance of considering PA in AD diagnosis, particularly in younger patients where medial temporal atrophy may be less conspicuous. Elsevier 2012-03 /pmc/articles/PMC3657170/ /pubmed/21596458 http://dx.doi.org/10.1016/j.neurobiolaging.2011.04.003 Text en © 2012 Elsevier Inc. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license |
spellingShingle | Abstract of Online Article Lehmann, Manja Koedam, Esther L.G.E. Barnes, Josephine Bartlett, Jonathan W. Ryan, Natalie S. Pijnenburg, Yolande A.L. Barkhof, Frederik Wattjes, Mike P. Scheltens, Philip Fox, Nick C. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease |
title | Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease |
title_full | Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease |
title_fullStr | Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease |
title_full_unstemmed | Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease |
title_short | Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease |
title_sort | posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed alzheimer's disease |
topic | Abstract of Online Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657170/ https://www.ncbi.nlm.nih.gov/pubmed/21596458 http://dx.doi.org/10.1016/j.neurobiolaging.2011.04.003 |
work_keys_str_mv | AT lehmannmanja posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT koedamestherlge posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT barnesjosephine posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT bartlettjonathanw posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT ryannatalies posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT pijnenburgyolandeal posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT barkhoffrederik posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT wattjesmikep posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT scheltensphilip posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease AT foxnickc posteriorcerebralatrophyintheabsenceofmedialtemporallobeatrophyinpathologicallyconfirmedalzheimersdisease |